These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9668269)

  • 1. Production of Fab fragments against the human acetylcholine receptor from myasthenia gravis thymus lambda and kappa phage libraries.
    Matthews I; Farrar J; McLachlan S; Rapoport B; Newsom-Davis J; Willcox N; Vincent A
    Ann N Y Acad Sci; 1998 May; 841():418-21. PubMed ID: 9668269
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiacetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF; de Baets MH; Burton DR
    Ann N Y Acad Sci; 1998 May; 841():414-7. PubMed ID: 9668268
    [No Abstract]   [Full Text] [Related]  

  • 3. Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library.
    Farrar J; Portolano S; Willcox N; Vincent A; Jacobson L; Newsom-Davis J; Rapoport B; McLachlan SM
    Int Immunol; 1997 Sep; 9(9):1311-8. PubMed ID: 9310834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-acetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF; de Baets MH; van Breda Vriesman PJ; Burton DR
    Immunol Lett; 1997 Jun; 57(1-3):59-62. PubMed ID: 9232426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
    Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
    Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Kirvan CA; Zhu S; Richman DP; Agius MA
    Ann N Y Acad Sci; 1998 May; 841():466-8. PubMed ID: 9668275
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic and functional characterization of human autoantibodies using combinatorial phage display libraries.
    Zeidel M; Rey E; Tami J; Fischbach M; Sanz I
    Ann N Y Acad Sci; 1995 Sep; 764():559-64. PubMed ID: 7486584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-acetylcholine receptor antibodies and myasthenia gravis (author's transl)].
    Nishitani H
    Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1578-83. PubMed ID: 7229476
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
    Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF; de Baets MH; Parren PW; Berrih-Aknin S; Wokke J; van Breda Vriesman PJ; Burton DR
    J Immunol; 1997 Feb; 158(4):1919-29. PubMed ID: 9029134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
    Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
    Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies.
    Katzberg HD; Aziz T; Oger J
    Neurology; 2001 Feb; 56(4):572-3. PubMed ID: 11222815
    [No Abstract]   [Full Text] [Related]  

  • 15. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.
    Newsom-Davis J; Willcox N; Calder L
    N Engl J Med; 1981 Nov; 305(22):1313-8. PubMed ID: 7290153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Km3 allotype with increased serum levels of autoantibodies against muscle acetylcholine receptor in myasthenia gravis.
    Dondi E; Gajdos P; Bach JF; Garchon HJ
    J Neuroimmunol; 1994 May; 51(2):221-4. PubMed ID: 8182118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of acetylcholine receptor-protecting Fab fragments with polyethylene glycol results in a prolonged half-life in the circulation and reduced immunogenicity.
    Trakas N; Tzartos SJ
    J Neuroimmunol; 2001 Nov; 120(1-2):42-9. PubMed ID: 11694318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short review of progress in experimental myasthenia gravis, bearing on the pathogenesis of myasthenia gravis.
    Heilbronn E
    Prog Brain Res; 1979; 49():459-63. PubMed ID: 390612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.